Literature DB >> 21314743

The role of cell plasticity in progression and reversal of renal fibrosis.

Jean-Claude Dussaule1, Dominique Guerrot, Anne-Cécile Huby, Christos Chadjichristos, Nasim Shweke, Jean-Jacques Boffa, Christos Chatziantoniou.   

Abstract

The need for novel insights into the mechanisms of progression of renal disease has become urgent during the last several years because of the increasing incidence of chronic renal disease worldwide. Independent of the underlying disease, the subsequent progression of renal fibrosis is characterized mainly by both an exaggerated synthesis and abnormal accumulation of extracellular matrix proteins produced by mesenchymal cells within the kidney. These cells are mainly myofibroblasts deriving from a variety of renal cells such as vascular smooth muscle, mesangial, resident stem, tubular epithelial, vascular endothelial cells or pericytes. The appearance of myofibroblasts is a reversible process, as suggested by studies in experimental models showing regression of renal fibrosis during therapy with antagonists and/or blockers of the renin-angiotensin system. An additional factor that can also affect the mechanisms of progression/regression of fibrosis is the plasticity of podocytes controlling glomerular filtration.
© 2011 The Authors. International Journal of Experimental Pathology © 2011 International Journal of Experimental Pathology.

Entities:  

Mesh:

Year:  2011        PMID: 21314743      PMCID: PMC3101488          DOI: 10.1111/j.1365-2613.2011.00760.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  56 in total

Review 1.  Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention.

Authors:  Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

Review 2.  The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease.

Authors:  S Klahr; J J Morrissey
Journal:  Kidney Int Suppl       Date:  2000-04       Impact factor: 10.545

3.  Regression of renal vascular fibrosis by endothelin receptor antagonism.

Authors:  J J Boffa; P L Tharaux; J C Dussaule; C Chatziantoniou
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

4.  Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-mediated mechanism.

Authors:  J J Boffa; P L Tharaux; S Placier; R Ardaillou; J C Dussaule; C Chatziantoniou
Journal:  Circulation       Date:  1999-11-02       Impact factor: 29.690

5.  Angiotensin II activates collagen type I gene in the renal cortex and aorta of transgenic mice through interaction with endothelin and TGF-beta.

Authors:  Fadi Fakhouri; Sandrine Placier; Raymond Ardaillou; Jean-Claude Dussaule; Christos Chatziantoniou
Journal:  J Am Soc Nephrol       Date:  2001-12       Impact factor: 10.121

Review 6.  Renal fibrosis and the renin-angiotensin system.

Authors:  A B Fogo
Journal:  Adv Nephrol Necker Hosp       Date:  2001

7.  Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway.

Authors:  P L Tharaux; C Chatziantoniou; F Fakhouri; J C Dussaule
Journal:  Hypertension       Date:  2000-09       Impact factor: 10.190

Review 8.  Epithelial-mesenchymal transition and its implications for fibrosis.

Authors:  Raghu Kalluri; Eric G Neilson
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

9.  Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition.

Authors:  Hélène François; Sandrine Placier; Martin Flamant; Pierre-Louis Tharaux; Dominique Chansel; Jean-Claude Dussaule; Christos Chatziantoniou
Journal:  FASEB J       Date:  2004-03-19       Impact factor: 5.191

10.  AT1 receptor expression in glomeruli from NO-deficient rats.

Authors:  Sophie Vandermeersch; Vadislav Stefanovic; Annette Hus-Citharel; Raymond Ardaillou; Jean-Claude Dussaule; Dominique Chansel
Journal:  Nephron Exp Nephrol       Date:  2003
View more
  19 in total

1.  Benefical therapeutic effect of Chinese Herbal Xinji'erkang formula on hypertension-induced renal injury in the 2-kidney-1-clip hypertensive rats.

Authors:  Ling-Ling Huang; Chen Pan; Ting-Ting Yu; Kun Guo; Xing-Hui Wang; Jun-Yan Zhang; Hong-Zhi Wang; Shan Gao
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-08-23

Review 2.  The roles of microRNAs on tuberculosis infection: meaning or myth?

Authors:  Harapan Harapan; Fitra Fitra; Ichsan Ichsan; Mulyadi Mulyadi; Paolo Miotto; Nabeeh A Hasan; Marta Calado; Daniela M Cirillo
Journal:  Tuberculosis (Edinb)       Date:  2013-08-15       Impact factor: 3.131

Review 3.  Renal interstitial fibrosis: mechanisms and evaluation.

Authors:  Alton B Farris; Robert B Colvin
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

4.  Experimental models of renal disease.

Authors:  Richard Poulsom
Journal:  Int J Exp Pathol       Date:  2011-06       Impact factor: 1.925

Review 5.  cAMP and Epac in the regulation of tissue fibrosis.

Authors:  Paul A Insel; Fiona Murray; Utako Yokoyama; Silvia Romano; Hongruo Yun; Loren Brown; Aaron Snead; David Lu; Nakon Aroonsakool
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

6.  Resident mesenchymal cells and fibrosis.

Authors:  Nicol Hutchison; Cécile Fligny; Jeremy S Duffield
Journal:  Biochim Biophys Acta       Date:  2012-12-04

7.  Gene expression profiles reveal molecular mechanisms involved in the progression and resolution of bleomycin-induced lung fibrosis.

Authors:  Sandra Cabrera; Moises Selman; Alfredo Lonzano-Bolaños; Kazuhisa Konishi; Thomas J Richards; Naftali Kaminski; Annie Pardo
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-03-01       Impact factor: 5.464

Review 8.  Stem cells: potential and challenges for kidney repair.

Authors:  Marcela Herrera; Maria Mirotsou
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-06

9.  Myofibroblast persistence with real-time changes in boundary stiffness.

Authors:  Mehmet H Kural; Kristen L Billiar
Journal:  Acta Biomater       Date:  2015-12-19       Impact factor: 8.947

10.  Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy.

Authors:  Dominique Guerrot; Jean-Claude Dussaule; Mouna Mael-Ainin; Yi-Chun Xu-Dubois; Eric Rondeau; Christos Chatziantoniou; Sandrine Placier
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.